AMGEN INC — Director's Dealing 2014

Apr 29, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2014-04-25

Reporting Person: Dittrich Thomas J.W. (VP, Finance & CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-25	Common Stock	F	312	$113.72	Disposed	18343	Direct
2014-04-25	Common Stock	A	681	—	Acquired	19024	Direct
2014-04-26	Common Stock	F	170	$111.41	Disposed	18854	Direct
2014-04-27	Common Stock	F	255	$111.41	Disposed	18599	Direct
2014-04-27	Common Stock	F	10	$111.41	Disposed	18589	Direct

Footnotes

F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/25/2016, 4/25/2017 and 4/25/2018, respectively.

F2: The shares include the following RSUs granted under the Company's equity plans: 583 RSUs which vest in one installment of 583 on 4/25/2015; 938 RSUs which vest in two installments of 462 on 4/27/2015 and 476 on 4/27/2016; 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively; and 681 RSUs which vest in annual installments of 224, 225 and 232 on 4/25/2015, 4/25/2017 and 4/25/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3: These shares include 40 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.